Naito Tatsuhiko, Inoue Kosuke, Namba Shinichi, Sonehara Kyuto, Suzuki Ken, Matsuda Koichi, Kondo Naoki, Toda Tatsushi, Yamauchi Toshimasa, Kadowaki Takashi, Okada Yukinori
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Commun Med (Lond). 2024 Sep 20;4(1):181. doi: 10.1038/s43856-024-00596-7.
Although polygenic risk scores (PRSs) are expected to be helpful in precision medicine, it remains unclear whether high-PRS groups are more likely to benefit from preventive interventions for diseases. Recent methodological advancements enable us to predict treatment effects at the individual level.
We employed causal forest to explore the relationship between PRSs and individual risk of diseases associated with certain environmental factors. Following simulations illustrating its performance, we applied our approach to investigate the individual risk of cardiometabolic diseases, including coronary artery diseases (CAD) and type 2 diabetes (T2D), associated with obesity and smoking among individuals from UK Biobank (UKB; n = 369,942) and BioBank Japan (BBJ; n = 149,421).
Here we find the heterogeneous association of obesity and smoking with diseases across PRS values, complicated by the multi-dimensional combination of individual characteristics such as age and sex. The highest positive correlations of PRSs and the exposure-related disease risks are observed between obesity and T2D in UKB and between smoking and CAD in BBJ (Spearman's ρ = 0.61 and 0.32, respectively). However, most relationships are weak or negative, suggesting that high-PRS groups will not necessarily benefit most from environmental factor prevention.
Our study highlights the importance of individual-level prediction of disease risks associated with target exposure in precision medicine.
尽管多基因风险评分(PRSs)有望在精准医学中发挥作用,但高PRS组是否更有可能从疾病的预防性干预中获益仍不清楚。最近的方法学进展使我们能够在个体水平上预测治疗效果。
我们采用因果森林来探索PRSs与与某些环境因素相关的疾病个体风险之间的关系。在通过模拟说明其性能之后,我们应用我们的方法来研究来自英国生物银行(UKB;n = 369,942)和日本生物银行(BBJ;n = 149,421)的个体中与肥胖和吸烟相关的心血管代谢疾病的个体风险,包括冠状动脉疾病(CAD)和2型糖尿病(T2D)。
在这里,我们发现肥胖和吸烟与疾病的关联在PRS值之间存在异质性,年龄和性别等个体特征的多维组合使情况变得复杂。在UKB中,肥胖与T2D之间以及在BBJ中,吸烟与CAD之间观察到PRSs与暴露相关疾病风险的最高正相关(斯皮尔曼相关系数ρ分别为0.61和0.32)。然而,大多数关系是微弱的或负相关的,这表明高PRS组不一定能从环境因素预防中获益最多。
我们的研究强调了在精准医学中对与目标暴露相关的疾病风险进行个体水平预测的重要性。